• J Matías-Guiu, J A Matias-Guiu, J Alvarez-Sabin, J Ramon Ara, J Arenillas, I Casado-Naranjo, M Castellanos, M D Jimenez-Hernandez, J M Lainez-Andres, E Moral, A Morales, A Rodriguez-Antigüedad, T Segura, P Serrano-Castro, and E Diez-Tejedor.
• Servicio de Neurología, Hospital Clínico San Carlos, Madrid, España. Electronic address: neurol.hcsc@salud.madrid.
• Neurologia. 2020 May 1; 35 (4): 252-257.

IntroductionThe COVID-19 pandemic will give rise to long-term changes in neurological care, which are not easily predictable.Material And MethodsA key informant survey was used to enquire about the changes expected in the specialty over the next 5 years. The survey was completed by heads of neurology departments with broad knowledge of the situation, having been active during the pandemic.ResultsDespite a low level of consensus between participants, there was strong (85%) and moderate consensus (70%) about certain subjects, mainly the increase in precautions to be taken, the use of telemedicine and teleconsultations, the reduction of care provided in in-person consultations to avoid the presence of large numbers of people in waiting rooms, the development of remote training solutions, and the changes in monitoring visits during clinical trials. There was consensus that there would be no changes to the indication of complementary testing or neurological examination.ConclusionThe key informant survey identified the foreseeable changes in neurological care after the pandemic.Copyright © 2020 Sociedad Española de Neurología. Publicado por Elsevier España, S.L.U. All rights reserved.

39 keywords...

hide…